Skip to content

Clinical trials

Terminated Phase 1 Lymphoma, B-Cell, Marginal Zone trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell, Marginal Zone Phase: Phase 1 Status: Terminated Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20042
20052
20061
20072
20083
20091
20102
20122
20132
20142
20152
20161
20182
20192
20213
20222
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated42

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)8
Masonic Cancer Center, University of Minnesota3
Barbara Ann Karmanos Cancer Institute2
Case Comprehensive Cancer Center2
City of Hope Medical Center2
Gilead Sciences2
MEI Pharma, Inc.2
TG Therapeutics, Inc.2
University of Medicine and Dentistry of New Jersey2
AbbVie1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell, Marginal Zone42
Lymphoma, Follicular39
Leukemia, Lymphocytic, Chronic, B-Cell36
Lymphoma, Mantle-Cell34
Lymphoma, Large B-Cell, Diffuse32
Lymphoma, Non-Hodgkin30
Precursor Cell Lymphoblastic Leukemia-Lymphoma23
Burkitt Lymphoma22
Lymphoma, Large-Cell, Immunoblastic21
Waldenstrom Macroglobulinemia19

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.